Substituted 2,3,4,5,7,9,13,13a-octahydropyrido[1′,2′:4,5]pyrazino[2,1-b][1,3]oxazepines and methods for treating viral infections
AssigneeGilead Sciences, Inc.
InventorsHaolun Jin, Scott E. Lazerwith, Hyung-Jung Pyun
Life of this patent
Estimating the term…
Abstract
Compounds for use in the treatment of human immunodeficiency virus (HIV) infection are disclosed. The compounds have the following Formula (I): including stereoisomers and pharmaceutically acceptable salts thereof, wherein R1, X, W, Y1, Y2, Z1, and Z4are as defined herein. Methods associated with preparation and use of such compounds, as well as pharmaceutical compositions comprising such compounds, are also disclosed.
Claims6
A compound which is:
- or a pharmaceutically acceptable salt thereof.
A pharmaceutical composition comprising a compound which is:
- or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier, diluent or excipient.
A compound which is:
- or a pharmaceutically acceptable salt thereof.
A pharmaceutical composition comprising a compound which is:
- or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier, diluent or excipient.
A compound which is:
- or a pharmaceutically acceptable salt thereof.
A pharmaceutical composition comprising a compound which is:
- or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier, diluent or excipient.
Dependencies are inferred from the claim text.